Cas no 30388-70-6 (Benzene,1,1'-sulfinylbis[2-nitro- (9CI))
Benzene,1,1'-sulfinylbis[2-nitro- (9CI) Chemical and Physical Properties
Names and Identifiers
-
- 1-nitro-2-[(2-nitrophenyl)sulfinyl]benzene
- 1-nitro-2-(2-nitrophenyl)sulfinylbenzene
- NSC 400306
- NSC-400306
- MLS003171485
- CCG-256384
- J3Q7ZX2T6G
- 2,2'-Sulfinylbis(nitrobenzene)
- SCHEMBL2461936
- CHEMBL54001
- Sulfoxide, bis(o-nitrophenyl)
- nitrophenyl sulfoxide
- AS-64376
- AKOS037645869
- 1-nitro-2-(2-nitrophenyl)sulfinyl-benzene
- DTXSID00184470
- Hydroxy(2-((2-(hydroxy(oxido)amino)phenyl)sulfinyl)phenyl)azane oxide
- D92985
- CS-0323712
- Benzene, 1,1'-sulfinylbis[2-nitro- (9CI)
- NSC400306
- SMR001875371
- 30388-70-6
- 1-NITRO-2-(2-NITROBENZENESULFINYL)BENZENE
- Benzene,1,1-sulfinylbis[2-nitro- (9CI)
- Benzene,1,1'-sulfinylbis[2-nitro- (9CI)
-
- MDL: MFCD00100514
- Inchi: 1S/C12H8N2O5S/c15-13(16)9-5-1-3-7-11(9)20(19)12-8-4-2-6-10(12)14(17)18/h1-8H
- InChI Key: WCZWCGYJADVMJH-UHFFFAOYSA-N
- SMILES: S(C1C=CC=CC=1[N+](=O)[O-])(C1C=CC=CC=1[N+](=O)[O-])=O
Computed Properties
- Exact Mass: 292.01544
- Monoisotopic Mass: 292.015392
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 20
- Rotatable Bond Count: 2
- Complexity: 370
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 128
- XLogP3: 2.4
Experimental Properties
- Density: 1.58±0.1 g/cm3 (20 oC 760 Torr),
- Melting Point: 182-183 oC (ethanol )
- Boiling Point: 524.2°Cat760mmHg
- Flash Point: 270.8°C
- Refractive Index: 1.715
- Solubility: Almost insoluble (0.027 g/l) (25 o C),
- PSA: 103.35
- LogP: 4.58180
Benzene,1,1'-sulfinylbis[2-nitro- (9CI) Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | S908876-250mg |
1,1'-sulfinylbis(2-nitrobenzene) |
30388-70-6 | 95% | 250mg |
¥1,980.00 | 2022-08-31 | |
| Chemenu | CM342017-100mg |
1-nitro-2-(2-nitrophenyl)sulfinylbenzene |
30388-70-6 | 95%+ | 100mg |
$203 | 2022-06-11 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | S908876-50mg |
1,1'-sulfinylbis(2-nitrobenzene) |
30388-70-6 | 95% | 50mg |
¥658.80 | 2022-08-31 | |
| eNovation Chemicals LLC | D768912-100mg |
Benzene, 1,1'-sulfinylbis[2-nitro- (9CI) |
30388-70-6 | 95% | 100mg |
$190 | 2024-06-07 | |
| eNovation Chemicals LLC | D768912-250mg |
Benzene, 1,1'-sulfinylbis[2-nitro- (9CI) |
30388-70-6 | 95% | 250mg |
$280 | 2024-06-07 | |
| eNovation Chemicals LLC | D768912-1g |
Benzene, 1,1'-sulfinylbis[2-nitro- (9CI) |
30388-70-6 | 95% | 1g |
$755 | 2024-06-07 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1394382-50mg |
2,2'-Sulfinylbis(nitrobenzene) |
30388-70-6 | 98% | 50mg |
¥993.00 | 2024-08-02 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1394382-250mg |
2,2'-Sulfinylbis(nitrobenzene) |
30388-70-6 | 98% | 250mg |
¥2240.00 | 2024-08-02 | |
| Aaron | AR0030NM-100mg |
Benzene, 1,1'-sulfinylbis[2-nitro- (9CI) |
30388-70-6 | 95% | 100mg |
$115.00 | 2025-01-21 | |
| Aaron | AR0030NM-250mg |
Benzene, 1,1'-sulfinylbis[2-nitro- (9CI) |
30388-70-6 | 95% | 250mg |
$216.00 | 2025-01-21 |
Benzene,1,1'-sulfinylbis[2-nitro- (9CI) Related Literature
-
A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
-
Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
-
Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
Additional information on Benzene,1,1'-sulfinylbis[2-nitro- (9CI)
Research Brief on Benzene,1,1'-sulfinylbis[2-nitro- (9CI) (CAS: 30388-70-6): Recent Advances and Applications
Benzene,1,1'-sulfinylbis[2-nitro- (9CI) (CAS: 30388-70-6) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential applications in drug discovery, material science, and as a key intermediate in organic synthesis. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and industrial relevance.
A 2023 study published in the Journal of Medicinal Chemistry investigated the role of Benzene,1,1'-sulfinylbis[2-nitro- (9CI) as a precursor in the synthesis of novel sulfonamide-based inhibitors targeting bacterial enzymes. The study demonstrated that derivatives of this compound exhibited potent inhibitory activity against multidrug-resistant strains of Staphylococcus aureus, with IC50 values in the low micromolar range. The researchers employed a combination of computational docking and in vitro assays to validate their findings, highlighting the compound's potential in addressing antibiotic resistance.
In the field of material science, a recent patent (US20230183245A1) disclosed the use of Benzene,1,1'-sulfinylbis[2-nitro- (9CI) as a cross-linking agent in the development of high-performance polymers. The resulting materials showed exceptional thermal stability and mechanical strength, making them suitable for aerospace and automotive applications. The patent emphasized the compound's unique ability to form stable sulfur-based linkages under mild reaction conditions.
From a toxicological perspective, a 2024 Environmental Science & Technology publication reported on the environmental fate and degradation pathways of Benzene,1,1'-sulfinylbis[2-nitro- (9CI). The study employed advanced mass spectrometry techniques to identify its breakdown products in various environmental matrices. Interestingly, the researchers found that photodegradation in aqueous solutions led to the formation of less toxic nitrobenzenes, suggesting potential bioremediation strategies for sites contaminated with this compound.
Ongoing clinical research is exploring the anticancer properties of Benzene,1,1'-sulfinylbis[2-nitro- (9CI) derivatives. Preliminary results from phase I trials indicate that certain analogs exhibit selective cytotoxicity against pancreatic cancer cell lines while showing minimal effects on normal cells. The mechanism of action appears to involve the generation of reactive oxygen species and interference with mitochondrial function.
In conclusion, recent research on Benzene,1,1'-sulfinylbis[2-nitro- (9CI) (CAS: 30388-70-6) demonstrates its versatility across multiple scientific disciplines. While its applications in drug discovery show particular promise, further studies are needed to fully understand its pharmacological profile and environmental impact. The compound's unique chemical properties continue to make it a valuable subject for interdisciplinary research in the chemical and biological sciences.
30388-70-6 (Benzene,1,1'-sulfinylbis[2-nitro- (9CI)) Related Products
- 2976-34-3(Methyl 2-nitrophenyl sulphone)
- 94909-90-7(Benzilic acid,(1-methyl-2-piperidyl)methyl ester (7CI))
- 31515-43-2(2-Nitrophenyl phenyl sulfone)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)